Full Text
Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands

Abstract

Authors

H.G.M. van Haalen M. Pompen K. Bergenheim P. McEwan R. Townsend M. Roudaut

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×